Approval · Notice of Compliance 13960 · 2012
PROQUAD: Notice of Compliance 13960
Issued December 21, 2012
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 13960
- Date
- December 21, 2012
- Company
- Merck Canada IncKirkland, Quebec, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Active immunizing agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PROQUAD | 02399229 | Marketed |
Medicinal ingredients
- MEASLES VIRUS VACCINE LIVE ATTENUATED 3 L10T50 per DOSE
- VARICELLA ZOSTER VIRUS 3.99 L10PFU per DOSE
- MUMPS VIRUS VACCINE LIVE ATTENUATED JERYL LYNN STRAIN 4.3 L10T50 per DOSE
- RUBELLA VIRUS VACCINE LIVE ATTENUATED WISTAR RA27/3 STRAIN 3 L10T50 per DOSE